Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment

Scand J Rheumatol. 2024 Mar;53(2):146-148. doi: 10.1080/03009742.2023.2274707. Epub 2023 Nov 30.
No abstract available

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / complications
  • Arthritis, Rheumatoid* / drug therapy
  • Azetidines* / therapeutic use
  • Humans
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / etiology
  • Purines*
  • Pyrazoles*
  • Sulfonamides / therapeutic use
  • Treatment Outcome

Substances

  • baricitinib
  • Azetidines
  • Sulfonamides
  • Antirheumatic Agents
  • Purines
  • Pyrazoles